103 related articles for article (PubMed ID: 8862727)
41. Induction of mutations in V79-4 mammalian cells under hypoxic and aerobic conditions by the cytotoxic 2-nitroimidazole-aziridines, RSU-1069 and RSU-1131. The influence of cellular glutathione.
Sapora O; Paone A; Maggi A; Jenner TJ; O'Neill P
Biochem Pharmacol; 1992 Oct; 44(7):1341-7. PubMed ID: 1417957
[TBL] [Abstract][Full Text] [Related]
42. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo.
Rauth AM; Mohindra JK; Tannock IF
Cancer Res; 1983 Sep; 43(9):4154-8. PubMed ID: 6409398
[TBL] [Abstract][Full Text] [Related]
43. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells.
Wallner KE; Banda M; Li GC
Cancer Res; 1987 Mar; 47(5):1308-12. PubMed ID: 3102043
[TBL] [Abstract][Full Text] [Related]
44. Hypoxia enhances the lethality of mitomycin C and carboquone against human malignant tumor cells in vitro.
Kusumoto T; Maehara Y; Sakaguchi Y; Saku M; Sugimachi K
Eur Surg Res; 1989; 21(3-4):224-31. PubMed ID: 2509206
[TBL] [Abstract][Full Text] [Related]
45. Biochemical and genetic analysis of the Chinese hamster mutants irs1 and irs2 and their comparison to cultured ataxia telangiectasia cells.
Jones NJ; Stewart SA; Thompson LH
Mutagenesis; 1990 Jan; 5(1):15-23. PubMed ID: 2158612
[TBL] [Abstract][Full Text] [Related]
46. Changes in the template activity of chromatin isolated from sarcoma-180 ascites cells treated with mitomycin C and gamma irradiation in vivo.
Karuri A; Mukherji S
Neoplasma; 1989; 36(3):321-6. PubMed ID: 2500608
[TBL] [Abstract][Full Text] [Related]
47. Correlation between cell survival and micronuclei formation in V79 cells treated with vindesine before exposure to different doses of gamma-radiation.
Jagetia GC; Adiga SK
Mutat Res; 2000 Mar; 448(1):57-68. PubMed ID: 10751623
[TBL] [Abstract][Full Text] [Related]
48. Cyclopropyl indolequinones: mechanistic probes for bioreductive anticancer drug action.
Moody CJ; Norton CL; Slawin AM; Taylor S
Anticancer Drug Des; 1998 Sep; 13(6):611-34. PubMed ID: 9755721
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51.
Gustafson DL; Pritsos CA
Cancer Chemother Pharmacol; 1991; 28(3):228-30. PubMed ID: 1906786
[TBL] [Abstract][Full Text] [Related]
50. [Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice].
Nishiyama M; Kim R; Saeki T; Takagami S; Kirihara Y; Jinushi K; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3133-7. PubMed ID: 3142368
[TBL] [Abstract][Full Text] [Related]
51. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions.
Begleiter A; Leith MK
Mol Pharmacol; 1993 Jul; 44(1):210-5. PubMed ID: 8341273
[TBL] [Abstract][Full Text] [Related]
52. Activation of mitomycin C by NADPH:cytochrome P-450 reductase.
Bligh HF; Bartoszek A; Robson CN; Hickson ID; Kasper CB; Beggs JD; Wolf CR
Cancer Res; 1990 Dec; 50(24):7789-92. PubMed ID: 2123741
[TBL] [Abstract][Full Text] [Related]
53. Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells.
Hennequin C; Giocanti N; Balosso J; Favaudon V
Cancer Res; 1994 Apr; 54(7):1720-8. PubMed ID: 8137287
[TBL] [Abstract][Full Text] [Related]
54. [Analysis of the mechanism of cancer metastasis by using anticancer agents].
Ozaki A; Saijo N; Beppu Y; Takahashi K; Shimizu E; Kimata M; Hoshi A
Gan To Kagaku Ryoho; 1984 Feb; 11(2):279-84. PubMed ID: 6421247
[TBL] [Abstract][Full Text] [Related]
55. Modification of potentially lethal damage in irradiated Chinese hamster V79 cells after incorporation of halogenated pyrimidines.
Franken NA; Van Bree CV; Kipp JB; Barendsen GW
Int J Radiat Biol; 1997 Jul; 72(1):101-9. PubMed ID: 9246199
[TBL] [Abstract][Full Text] [Related]
56. Enhancement of mitomycin-C cytotoxicity by combination with flavone acetic acid in a murine tumour.
Parkins CS; Denekamp J; Chaplin DJ
Anticancer Res; 1993; 13(5A):1437-42. PubMed ID: 8239516
[TBL] [Abstract][Full Text] [Related]
57. Resistance of hypoxic cells to ionizing radiation is influenced by homologous recombination status.
Sprong D; Janssen HL; Vens C; Begg AC
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):562-72. PubMed ID: 16343804
[TBL] [Abstract][Full Text] [Related]
58. Effect of acute and chronic intermittent hypoxia on DNA topoisomerase II alpha expression and mitomycin C-induced DNA damage and cytotoxicity in human colon cancer cells.
Kang Y; Greaves B; Perry RR
Biochem Pharmacol; 1996 Aug; 52(4):669-76. PubMed ID: 8759040
[TBL] [Abstract][Full Text] [Related]
59. Distinct DNA Damage Spectra Induced by Ionizing Radiation in Normoxic and Hypoxic Cells.
Shimizu N; Ooka M; Takagi T; Takeda S; Hirota K
Radiat Res; 2015 Oct; 184(4):442-8. PubMed ID: 26430822
[TBL] [Abstract][Full Text] [Related]
60. [A clinical trial of a new mitomycin C derivative, KW-2083 (7-N-(p-hydroxyphenyl)-mitomycin C)].
Takahashi K; Yokoyama M; Takahashi H; Wakui A
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1787-93. PubMed ID: 4037809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
